Showing results (121-130 of 290) with videos related to

Sort By:
Pageof 29
Rheumatology (Oxford, England)|October 31, 2015
ROUTINE-a prospective, multicentre, non-interventional, observational study to evaluate the safety and effectiveness of intravenous tocilizumab for the treatment of active rheumatoid arthritis in daily practice in GermanyChristof Iking-Konert, Ulrich von Hinüber, Constanze Richter, et al.
Cells|October 17, 2019
IL-2 Therapy Diminishes Renal Inflammation and the Activity of Kidney-Infiltrating CD4+ T Cells in Murine Lupus NephritisAngelika Rose, Caroline von Spee-Mayer, Lutz Kloke, et al.
Rheumatology International|April 9, 2011
Effect of biofeedback and deep oscillation on Raynaud's phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trialBirte Sporbeck, Kirsten Mathiske-Schmidt, Silke Jahr, et al.
Immunology Letters|April 6, 2010
Rimexolone inhibits proliferation, cytokine expression and signal transduction of human CD4+ T-cellsCornelia M Spies, Timo Gaber, Martin Hahne, et al.
Arthritis Research & Therapy|March 12, 2014
Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patientsJeannine Günther, Angela Kill, Mike Oliver Becker, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Serum cytokines and their predictive value in pulmonary involvement of systemic sclerosisMike Oliver Becker, Mislav Radic, Katrin Schmidt, et al.
Journal of Clinical Medicine|April 30, 2021
Impact of Different JAK Inhibitors and Methotrexate on Lymphocyte Proliferation and DNA DamageAnnika Reddig, Linda Voss, Karina Guttek, et al.
BMC Neurology|June 23, 2021
Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis - case reportMichaela Butryn, Sabine Mewes, Eugen Feist, et al.
BMC Musculoskeletal Disorders|December 9, 2014
Increased proteasome activator 28 gamma (PA28γ) levels are unspecific but correlate with disease activity in rheumatoid arthritisMelanie Gruner, Anja Moncsek, Stefan Rödiger, et al.
Arthritis Care & Research|August 30, 2018
Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical TrialsPhilip Mease, Euthalia Roussou, Gerd-Rüdiger Burmester, et al.
Pageof 29